We are live on ! Find out more
ECM

Everence Capital Management Portfolio holdings

AUM $1.9B
1-Year Est. Return 39.77%
This Fund
S&P 500
This Quarter Est. Return
+5.85%
1 Year Est. Return
+39.77%
3 Year Est. Return
+108.07%
5 Year Est. Return
+139.85%
10 Year Est. Return
+551.6%
AUM
$270M
AUM Growth
+$16M
Cap. Flow
+$2.67M
Cap. Flow %
0.99%
Top 10 Hldgs %
18.47%
Holding
276
New
10
Increased
19
Reduced
6
Closed
5

Top Buys

Rank Stock Value
1
GM icon
General Motors
GM
+$427K
2
VZ icon
Verizon
VZ
+$325K
3
LLY icon
Eli Lilly
LLY
+$229K
4
EW icon
Edwards Lifesciences
EW
+$213K
5
CTXS
Citrix Systems Inc
CTXS
+$208K

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$707K
2
FRX
FOREST LABORATORIES INC
FRX
+$420K
3
WFM
Whole Foods Market Inc
WFM
+$250K
4
NBR icon
Nabors Industries
NBR
+$247K
5
NVDA icon
NVIDIA
NVDA
+$211K

Sector Composition

Rank Sector Weight
1 Technology 16.94%
2 Financials 15.92%
3 Healthcare 14.37%
4 Energy 10.48%
5 Communication Services 10.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MCD icon
26
McDonald's
MCD
$176B
$2.26M 0.84%
22,471
+1,550
+7% +$156K
HD icon
27
Home Depot
HD
$304B
$2.17M 0.81%
26,843
– –
WMT icon
28
Walmart Inc
WMT
$845B
$2.17M 0.81%
86,832
– –
V icon
29
Visa
V
$689B
$2.15M 0.8%
40,776
– –
META icon
30
Meta Platforms (Facebook)
META
$1.72T
$2.11M 0.78%
31,373
+2,530
+9% +$156K
AMGN icon
31
Amgen
AMGN
$206B
$2.09M 0.78%
17,657
– –
AMZN icon
32
Amazon
AMZN
$2.71T
$2.09M 0.78%
128,720
– –
CSCO icon
33
Cisco
CSCO
$437B
$2.08M 0.77%
83,905
– –
ABBV icon
34
AbbVie
ABBV
$464B
$2.03M 0.75%
35,952
– –
AXP icon
35
American Express
AXP
$212B
$1.9M 0.71%
20,061
– –
DD
36
DELISTED
Du Pont De Nemours E I
DD
$1.83M 0.68%
29,481
+1,811
+7% +$116K
SE
37
DELISTED
Spectra Energy Corp Wi
SE
$1.78M 0.66%
42,022
– –
MDLZ icon
38
Mondelez International
MDLZ
$78.5B
$1.74M 0.65%
46,295
– –
LLY icon
39
Eli Lilly
LLY
$1.02T
$1.74M 0.65%
27,988
+3,840
+16% +$229K
UPS icon
40
United Parcel Service
UPS
$85.2B
$1.73M 0.64%
16,801
– –
BMY icon
41
Bristol-Myers Squibb
BMY
$130B
$1.71M 0.63%
35,197
– –
UNP icon
42
Union Pacific
UNP
$166B
$1.7M 0.63%
17,062
– –
UNH icon
43
UnitedHealth
UNH
$340B
$1.68M 0.62%
20,593
– –
MA icon
44
Mastercard
MA
$495B
$1.67M 0.62%
22,680
– –
MDT icon
45
Medtronic
MDT
$118B
$1.65M 0.61%
25,801
– –
PX
46
DELISTED
Praxair Inc
PX
$1.63M 0.6%
12,265
– –
EOG icon
47
EOG Resources
EOG
$75.6B
$1.62M 0.6%
13,870
– –
TWX
48
DELISTED
Time Warner Inc
TWX
$1.57M 0.58%
22,415
-1,423
-6% -$93.5K
BIIB icon
49
Biogen
BIIB
$32B
$1.53M 0.57%
4,859
– –
CVS icon
50
CVS Health
CVS
$117B
$1.48M 0.55%
19,593
– –
1
2
3 4 5

Similar funds

TS
Triglav Skladi Ljubljana, Slovenia $1.9B AUM 57.85% 1-Year Est. Return
JPM
JANA Partners Management New York $1.9B AUM 18.33% 1-Year Est. Return
PP
PDT Partners New York $1.9B AUM 71.86% 1-Year Est. Return
FVWA
Foster Victor Wealth Advisors Greenville, South Carolina $1.9B AUM 24.46% 1-Year Est. Return
DC
Dendur Capital New York $1.9B AUM 46.69% 1-Year Est. Return
VCA
Verdence Capital Advisors Hunt Valley, Maryland $1.9B AUM 36.41% 1-Year Est. Return
FCIM
Fairview Capital Investment Management Greenbrae, California $1.9B AUM 14.31% 1-Year Est. Return
MLL
Moody Lynn & Lieberson Boston, Massachusetts $1.9B AUM 27.82% 1-Year Est. Return

Everence Capital Management's Q2 2014 Portfolio in Review

As of Q2 2014, Everence Capital Management held 276 positions worth $270M, up 6.3% from $254M the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Everence Capital Management's Q2 2014 filing shows 10 new, 19 increased, 6 reduced and 5 closed positions. Its largest new stake was Edwards Lifesciences: 15,720 shares worth $225K. The largest sale was Celgene Corp, an estimated $707K.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

  • Everence Capital Management's largest Q2 2014 buy was Edwards Lifesciences: 15,720 shares worth $225K.
  • Everence Capital Management added most to General Motors in Q2 2014, an estimated $427K increase.
  • Everence Capital Management's biggest Q2 2014 reduction was Celgene Corp, cutting an estimated $707K.
  • Everence Capital Management fully exited FOREST LABORATORIES INC in Q2 2014, selling an estimated $420K.
  • Everence Capital Management's ten largest holdings make up 18% of its $270M portfolio in Q2 2014.
  • Everence Capital Management opened 10 new positions and closed 5 in Q2 2014.
  • Everence Capital Management's portfolio value rose 6.3% quarter-over-quarter to $270M.

Based on Everence Capital Management's 13F filing for Q2 2014, filed 4 Aug 2014.